Task: Answer the multiple-choice question.
Question: Which compound exhibits a -4.847\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a: CCCCCNC(=O)C1c2ccccc2Oc2ccccc21
b: Cc1cccn2cc(CNC(=O)c3ccco3)nc12
c: Cc1ccc2nc(SCC(=O)Nc3ccc(F)cc3F)nc(=O)n2c1
d: CC(C)n1c(NCc2c[nH]c3ccccc23)nc2ccccc21
Answer: d. CC(C)n1c(NCc2c[nH]c3ccccc23)nc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)n1c(NCc2c[nH]c3ccccc23)nc2ccccc21
CC(C)n1c(NCc2c[nH]c3ccccc23)nc2ccccc21
N-(1H-indol-3-ylmethyl)-1-propan-2-ylbenzimidazol-2-amine